Against the backdrop of increasing concerns around Omicron, last week we convened a media briefing on the biopharmaceutical industry’s efforts over the past year since the first COVID-19 vaccine was administered.
Read moreInnovation is crucial to identifying solutions to Africa’s healthcare needs. However, without the participation of women in the fields of Science, Technology, Engineering, and Mathematics (STEM), Africa and the world is bound to miss their invaluable perspectives and critical contributions.
Read moreThis press briefing took stock of the progress achieved in developing and scaling up COVID-19 vaccines production, and addressed the challenges that need to be tackled.
Read more
The Biotechnology Innovation Organization (BIO), Developing Countries Vaccine Manufacturers’ Network (DCVMN), and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing many of the companies behind the historic scale up of manufacturing of vaccines, released independent data that confirms production of COVID-19 vaccines scaled up from zero to 11,2 billion doses in just one year.
Read moreThomas Cueni calls for unrestricted access to pathogen sharing to help the world prepare for new variants and future pandemics.
Read moreThe focus of this paper is follow-on versions of smaller protein products developed to be marketed following expiry of patent and data protection of the reference product. They are synthetically produced while the reference product is manufactured recombinantly.
Read more
The transfer of advanced technology is essential for economic development. It enables countries to accelerate the acquisition of knowledge, experience and equipment related to advanced, innovative industrial products and processes. This, in turn, builds the skills of the local workforce and creates new high-tech employment opportunities.
Read more
In this blog, originally published on UHC2030, UHC2030’s Private Sector Constituency shares some examples of how the private sector contributes to strengthening health systems for UHC and health security.
Read moreIndustry acknowledges its commitment to continue improving its strategic and predictive planning and proactive communication of changes to help facilitate global supply.
Read more
It is difficult to predict the nature of the next health threat. We do not know where, how or when it will hit. What we know is that playing catch is a lost battle.
Read more3 December 2021 – COVID-19, the worst pandemic the world has seen in 100 years, has shown us that we cannot let our guard down. The global biopharmaceutical industry understands the concern caused by the emergence of the Omicron variant of COVID-19 since it was declared a variant of concern by the World Health Organization....
Read moreGlobal leaders from the pharmaceutical industry met with the Prime Minister, senior UK Cabinet Ministers and the NHS Chief Executive, to discuss global health and innovation.
Read more